SCHEMBL6003062

SCHEMBL6003062

[CH2]C(C)(C)c1ccc2ccoc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 5/20 0.39
CYP2A6 P11509 3/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
MAOA P21397 1/20 0.38
ACHE P22303 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTT P42858 1/20 0.37
EPM2A O95278 1/20 0.36
PTPRC P08575 1/20 0.36
PTPN6 P29350 1/20 0.36
CDC14A Q9UNH5 1/20 0.36
PTPN22 Q9Y2R2 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2609996 0.84 HTR1B (0.41) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL27097447 0.81 HTR1B (0.41) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL13713915 0.77 ESR1 (0.44) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL20858618 0.76 EPM2A (0.45) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL15582382 0.75 EPM2A (0.42) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL6090212 0.73 HTR1B (0.41) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL24111657 0.73 HTR1B (0.50) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL25483158 0.72 HTR1B (0.42) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL24111653 0.71 HTR1B (0.48) HTR1BCYP2A6KDM4ECYP3A4CYP2D6
SCHEMBL15590665 0.70 EPM2A (0.44) HTR1BCYP2A6KDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed